Nordea Investment Management Ab »

Crispr Therapeutics shares owned by Nordea Investment Management Ab

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Nordea Investment Management Ab from 13F filings

Historical chart of Nordea Investment Management Ab investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Nordea Investment Management Ab consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Nordea Investment Management Ab

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.7M 106k 63.23
2023-09-30 $5.0M 108k 46.65
2023-06-30 $5.5M 95k 57.59
2023-03-31 $4.5M 101k 44.94
2022-12-31 $4.0M 102k 39.70
2022-09-30 $5.8M 88k 65.82
2022-06-30 $5.4M 89k 60.79
2022-03-31 $6.3M 97k 64.60
2021-12-31 $7.5M 94k 80.22
2021-09-30 $17M 151k 112.39